IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding IGC Pharma, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 30 | 25 | −5 |
| Shares | 2.84M | 2.86M | +18.3K (+0.6%) |
| Value | $954.3K | $814.9K | −$139.4K (−14.6%) |
New holders (1)
Institutions that held IGC Pharma, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 32,083 | $9.14K | 0.00% |
Sold out (6)
Institutions that held IGC Pharma, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 60,863 | $20.4K |
| HRT Financial LP | 27,737 | $9.00K |
| Jane Street Group, LLC | 16,760 | $5.63K |
| Virtu Financial LLC | 12,196 | $4.00K |
| Advisor Group Holdings, Inc. | 3,031 | $1.03K |
| Caitlin John, LLC | 200 | $67 |